Last reviewed · How we verify

NCT06871072: TRHBN

Telerehabilitation for Multiple Sclerosis

Completed NA Last updated 19 September 2025
What this trial tests

NA trial testing Telerehabilitation in Multiple Sclerosis in 58 participants. Completed in 31 August 2025.

Timeline
1 April 2025
Primary endpoint
15 August 2025
31 August 2025

Quick facts

Lead sponsorUniversity of Cadiz
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment58
Start date1 April 2025
Primary completion15 August 2025
Estimated completion31 August 2025
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

University of Cadiz

Who can join

Adults 35 to 60, any sex, with Multiple Sclerosis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Multiple sclerosis (MS) is a neurodegenerative disease affecting the central nervous system and is a leading cause of disability in young adults. It often produces strength deficits. Exercise has been shown to improve strength, mobility, and quality of life while reducing fatigue. Telerehabilitation offers a convenient, accessible alternative for MS patients. This study explores the use of an AI-powered application for prescribing and monitoring strength exercises, ensuring continuous feedback and adherence. Methods: Randomized clinical trial. Intervention of 3 weekly strength training ses-sions for 20 weeks, patients in the experimental group used the AI application, while patients in the control group followed the conventional method, paper-based exercises with access to videos.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Telerehabilitation

Trials testing the same drug.

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

Other University of Cadiz trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06871072.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing